Spencer David M.

Bellicum Pharmaceuticals, Inc

Chief Technology Officer

Avg. Two Year Performance

No Purchase Track Record

70% Avg. Sale Return 31% Compound

Holdings: 92.47K shares

Last Three Months: 31-Jan-24 -- 30-Apr-24

0 Net Amount

Buy:	0	--
Sell:	0	--

Sentiment

Company Sentiment

Biotechnology

Drugs

Two Year Chart

01-May-22 -- 30-Apr-24

Price ($)

Two Year Stock Price Chart

Sentiment

Company Sentiment

Most Recent Insider Transactions